{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:15Z","timestamp":1785269895846,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clineuro.2021.106709","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T12:03:56Z","timestamp":1621944236000},"page":"106709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neuromyelitis optica spectrum disorder in Africa: What is the current state of knowledge?"],"prefix":"10.1016","volume":"206","author":[{"given":"Ademola S.","family":"Ojo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clineuro.2021.106709_bib1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.clineuro.2021.106709_bib2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2021.106709_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9451","key":"10.1016\/j.clineuro.2021.106709_bib4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clineuro.2021.106709_bib5","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2021.106709_bib6","first-page":"249","article-title":"Multiple sclerosis and neuromyelitis optica. Case report and speculation","volume":"60","author":"Cosnett","year":"1981","journal-title":"S. Afr. Med. J."},{"issue":"23","key":"10.1016\/j.clineuro.2021.106709_bib7","first-page":"987","article-title":"A possible case of neuromyelitis optica in a Bantu patient","volume":"47","author":"Hift","year":"1973","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.clineuro.2021.106709_bib8","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jnnp.57.9.1064","article-title":"Multiple sclerosis in black South Africans and Zimbabweans","volume":"57","author":"Dean","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2021.106709_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.msard.2019.02.012","article-title":"Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort","volume":"30","author":"Bennis","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2021.106709_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.msard.2018.10.108","article-title":"Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: a preliminary study of sixteen Senegalese cases","volume":"27","author":"Gaye","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.clineuro.2021.106709_bib11","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult. Scler. Int."},{"issue":"7","key":"10.1016\/j.clineuro.2021.106709_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106709_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0022-510X(71)90110-9","article-title":"The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria","volume":"12","author":"Osuntokun","year":"1971","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2021.106709_bib14","doi-asserted-by":"crossref","first-page":"A79","DOI":"10.1016\/j.neurol.2016.01.190","article-title":"La neuromy\u00e9lite optique (NMO) au Mali: quelle r\u00e9alit\u00e9\u202f?","volume":"172","author":"Maiga","year":"2016","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106709_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neurol.2018.05.003","article-title":"Inflammatory demyelinating diseases of the central nervous system in Niger","volume":"175","author":"Assadeck","year":"2019","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.clineuro.2021.106709_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.msard.2015.12.005","article-title":"Neuromyelitis optica spectrum disorders in Algeria: a preliminary study in the region of Tizi Ouzou","volume":"6","author":"Daoudi","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12 Pt 1","key":"10.1016\/j.clineuro.2021.106709_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0035-3787(05)85192-6","article-title":"La neuromy\u00e9lite optique au Maroc. Etude de neuf cas [Devic\u2019s neuromyelitis optica in Morocco. A study of 9-cases]","volume":"161","author":"El Otmani","year":"2005","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.clineuro.2021.106709_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106709_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4102\/sajhivmed.v18i1.684","article-title":"The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa","volume":"18","author":"Bhigjee","year":"2017","journal-title":"S. Afr. J. HIV Med."},{"issue":"12","key":"10.1016\/j.clineuro.2021.106709_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.5588\/ijtld.10.0780","article-title":"Neuromyelitis optica and pulmonary tuberculosis: a case-control study","volume":"15","author":"Zatjirua","year":"2011","journal-title":"Int J. Tube Lung Dis."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106709_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12868-020-0557-x","article-title":"Neuromyelitis optica: a pilot study of clinical presentation and status of serological biomarker AQP4 among patients admitted to a tertiary centre in NCNS, Sudan","volume":"21","author":"Ibrahim","year":"2020","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.clineuro.2021.106709_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jns.2017.08.3254","article-title":"Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: clinical and paraclinical characteristics in Algerian patients","volume":"381","author":"Bouzar","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106709_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jocn.2014.09.024","article-title":"Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients","volume":"22","author":"Kishk","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106709_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neurol.2019.08.009","article-title":"Neuromyelitis optica spectrum disorders in South of Tunisia: a rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies","volume":"176","author":"Mejdoub","year":"2020","journal-title":"Rev. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2021.106709_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7224\/1537-2073.2012-048","article-title":"The incidence and prevalence of neuromyelitis optica: a systematic review","volume":"15","author":"Marrie","year":"2013","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.clineuro.2021.106709_bib26","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.clineuro.2021.106709_bib27","article-title":"Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia","volume":"2","author":"Miskin","year":"2016","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"6","key":"10.1016\/j.clineuro.2021.106709_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.24649","article-title":"Neurology training in sub-Saharan Africa: a survey of people in training from 19 countries","volume":"79","author":"Mateen","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2021.106709_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.msard.2019.05.013","article-title":"Neuromyelitis optica testing and treatment: availability and affordability in 60 countries","volume":"33","author":"Holroyd","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.clineuro.2021.106709_bib30","doi-asserted-by":"crossref","first-page":"e1375","DOI":"10.1016\/S2214-109X(19)30374-2","article-title":"Burden of non-communicable diseases in sub-Saharan Africa, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Gouda","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.clineuro.2021.106709_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.11604\/pamj.2018.30.240.14000","article-title":"Survey of magnetic resonance imaging availability in West Africa","volume":"30","author":"Ogbole","year":"2018","journal-title":"Pan Afr. Med. J."},{"issue":"2","key":"10.1016\/j.clineuro.2021.106709_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2021.106709_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2021.106709_bib34","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/CON.0000000000000742","article-title":"Neuromyelitis optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases","volume":"25","author":"Flanagan","year":"2019","journal-title":"Continuum"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:37:42Z","timestamp":1759588662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"alternative-id":["S0303846721002389"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106709","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica spectrum disorder in Africa: What is the current state of knowledge?","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106709"}}